Skip to main content
TipRanks
Go Ultimate75% OFF

Solana Company (HSDT) AI Stock Analysis

426 Followers
HSDT

Solana Company

(NASDAQ:HSDT)

Select Model
Rating:60Neutral
Price Target:$1.50▲(0.67% Upside)
Action:reiterated
Date:11/13/26

HSDT scores highest on financial positioning and valuation: a no-debt balance sheet and very low P/E support the stock, and the earnings call reinforced operational progress and scaling of staking infrastructure. Offsetting these positives are weak cash flow (negative operating and free cash flow) and poor technicals (price below key moving averages with negative MACD), which together increase risk and limit the overall score.

Positive Factors
Staking Revenue GrowthRapid growth in staking revenue indicates expanding monetization of the company’s treasury and validator infrastructure. If delegation and institutional adoption continue, a larger recurring operating base could support durable revenue growth and improve the scalability of the business over the next several quarters.
Negative Factors
Negative Cash GenerationPersistent negative operating and free cash flow shows that reported profitability has not yet translated into internally generated cash. Continued burn could constrain investment capacity, increase reliance on equity financing, and make the recent earnings improvement less durable if cash conversion does not improve.

Solana Company (HSDT) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%HSDT-58.50%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$87.00M
Dividend Yield
―
Average Volume (3M)
580.12K
Price to Earnings (P/E)
0.4
Beta (1Y)
0.86
Revenue Growth
1465.89%
EPS Growth
―
Country
US
Employees
21
Sector
Financial
Sector Strength
68
Industry
Asset Management

Solana Company Business Overview & Revenue Model

Company Description

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies...

Solana Company Earnings Call Summary

Earnings Call Date:Nov 11, 2026(Q3-2026)|% Change Since:-19.89%|Next Earnings Date:Mar 11, 2027
Earnings Call SentimentPositive

The call was broadly positive, with management highlighting strong revenue growth, an 82% gross margin, reduced operating costs, a return to quarterly profitability, SOL treasury growth, above-network staking yields and faster-than-expected third-party delegation. The main challenges were the first-nine-month operating and net losses, realized digital asset losses, limited cash relative to obligations, potential expense normalization, moderating delegation growth and volatility in staking outperformance. The positive developments significantly outweighed the stated challenges.

Positive Updates

Third-Quarter Revenue Growth
Third-quarter revenue was $3.4 million, including $3.3 million of staking revenue and $23,000 of other revenue, compared with $697,000 in the third quarter of 2025 and $2.5 million in the second quarter of 2026. First-nine-month revenue was $9.5 million, including $9.3 million of staking revenue, compared with $789,000 in the prior-year period.

Negative Updates

First-Nine-Month Operating Loss
Despite third-quarter operating income of $103.9 million, the company reported a first-nine-month loss from operations of $28.4 million and a first-nine-month net loss of $24.9 million.

Company Guidance

For the fourth quarter, the company plans to grow Pacific Backbone’s third-party stake, complete its assessment of Hong Kong as its next validated location, work with ISO 27001 certification targeted for the fourth quarter of 2026, use its planned new regional headquarters in Hong Kong to bring more institutions on to Solana and grow its staking offering, and keep compounding SOL per share; it said OpEx would “probably normalize between what our current rate is and what our historic rate, something in between,” while “as the business grows, we would expect an increase in expenses,” third-party stake growth from 300,000 to over 1 million SOL is “probably going to slow down a bit in the fourth quarter,” it does not expect it to reach “$3 million by the end of the quarter,” and by “first quarter next year” it expects more third parties to come to its validated infrastructure; management also said it “should be able to continue to outperform,” should maintain “some performance gap,” but that “gap might be volatile quarter-to-quarter.”

Solana Company Financial Statement Overview

Summary

Reported profitability improved sharply in the TTM period with strong revenue growth and very high margins, and the balance sheet is conservatively positioned with essentially no debt and substantial equity. However, cash generation is a major weakness: operating cash flow and free cash flow are negative in TTM, and the multi-year history of losses makes the durability and quality of the earnings turnaround less certain.

Income Statement

62Positive

Balance Sheet

78Positive

Cash Flow

28Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.73M6.02M520.00K644.00K787.00K522.00K
Gross Profit13.68M5.52M-62.00K61.00K324.00K224.00K
EBITDA322.25M-39.58M-13.80M-12.11M-14.50M-17.82M
Net Income300.66M-40.89M-11.74M-8.85M-14.07M-18.13M
Balance Sheet
Total Assets292.65M303.93M3.54M7.69M17.29M14.10M
Cash, Cash Equivalents and Short-Term Investments1.13M7.28M1.09M5.18M14.55M11.01M
Total Debt0012.00K57.00K110.00K3,000
Total Liabilities26.41M3.02M2.48M5.34M9.14M2.85M
Stockholders Equity266.24M300.91M1.06M2.35M8.15M11.26M
Cash Flow
Free Cash Flow-25.97M-61.29M-11.05M-10.45M-14.33M-13.44M
Operating Cash Flow-25.97M-16.51M-11.04M-10.42M-14.31M-13.39M
Investing Cash Flow-144.84M-426.53M-5,000-29.00K-11.00K-56.00K
Financing Cash Flow47.88M449.24M6.95M1.08M17.87M21.13M

Solana Company Technical Analysis

Technical Analysis SentimentNegative
Last Price1.49

Price Trends

50DMA2.29Negative
100DMA2.08Negative
200DMA2.02Negative

Market Momentum

MACD-0.19Positive
RSI24.09Positive
STOCH17.88Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HSDT, the sentiment is Negative. The current price of 1.49 is below the 20-day moving average (MA) of 1.92, below the 50-day MA of 2.29, and below the 200-day MA of 2.02, indicating a bearish trend. The MACD of -0.19 indicates Positive momentum. The RSI at 24.09 is Positive, neither overbought nor oversold. The STOCH value of 17.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HSDT.

Solana Company Risk Analysis

Solana Company disclosed 45 risk factors in its most recent earnings report. Solana Company reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Nasdaq may delist our Common Stock from its exchange which could limit your ability to make transactions in our securities and subject us to additional trading restrictions.Q3, 2024
2.We are currently in the process of transitioning our manufacturing functions to a new contract manufacturer and any delays in the manufacturing process as a result of this transition could harm our business.Q4, 2023
3.Global macroeconomic instability could adversely affect our ability to raise additional financing.Q4, 2023

Solana Company Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

HSDT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
VMDVMD75Outperform$326.26M20.9210.78%―21.81%17.67%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
SGHTSGHT61Neutral$590.25M-19.64-51.66%―16.23%41.47%
HSDTHSDT60Neutral$104.39M0.39129.22%―1465.89%―
SNWVSNWV48Neutral$13.68M5.00113.13%―-0.61%―
OMOM47Neutral$54.86M-0.73-68.03%―1.58%70.22%
CVRXCVRX37Underperform$15.18M-0.25-208.45%―7.79%0.87%

* Financial Sector Average

Performance Comparison

-50%0%50%HSDTSNWVVMDOMCVRXSGHTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HSDT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HSDTSolana Company1.49-2.26-60.27%
SNWVSanuwave Health Inc.1.50-32.27-95.56%
VMDViemed Healthcare US8.521.6624.20%
OMOutset Medical, Inc.2.81-1.52-35.10%
CVRXCvrx, Inc.0.50-9.34-94.91%
SGHTSight Sciences, Inc.10.182.6935.91%

Solana Company Corporate Events

Business Operations and StrategyPrivate Placements and Financing

Solana Company Announces Premium-Priced Equity Offering

Positive
Sep 30, 2026

On September 30, 2026, Solana Company priced a $15 million registered direct offering with a single global institutional investor, selling 4,369,356 Class A shares at $3.433 each alongside equal-count warrants exercisable at $3.776 per share, both st...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026